Miles Gerson

Miles Gerson is a senior executive at Takeda Ventures, Inc., the corporate venturing arm of the Japan-headquartered pharmaceutical firm Takeda.1 As of April 2023, Gerson was promoted to the position of Executive Investment Director and Partner at Takeda Ventures.1

Career at Takeda Ventures

Gerson joined Takeda Ventures in April 2020 as a Partner.3 His role has evolved over time:

• Initially hired as a Partner in early 2020
• Took on an additional role as Senior Investment Director about 18 months later
• Served as interim head of gastrointestinal business development
• Promoted to Executive Investment Director and Partner in April 20231

Responsibilities and Expertise

Gerson is based in Cambridge, Massachusetts.3 His responsibilities at Takeda Ventures include:

• Making venture investments in life sciences technology developers
• Focusing on areas such as oncology, gastroenterology, neuroscience, and rare diseases1
• Serving on the boards of several portfolio companies, including Zelluna Immunotherapy, Integra Therapeutics, and Catamaran Bio1

Professional Background

Prior to joining Takeda Ventures, Gerson held several positions at Viridian Therapeutics (previously known as MiRagen Therapeutics):

• Senior Director of Business Development and Legal Affairs
• Corporate Counsel
• Compliance Officer1

Overall, Miles Gerson is a venture investment and business development professional with approximately 20 years of experience in the life sciences industry.2